Graham CollingridgeProfile page
Professor
Temerty Faculty of Medicine, Department of Physiology
Orcid identifier0000-0002-9572-5359
- ProfessorTemerty Faculty of Medicine, Department of Physiology
BIO
Graham Collingridge, FRS, CBE, is the Director of the Tanz Centre for Research in Neurodegenerative Diseases (CRND), a Professor in the Department of Physiology at the University of Toronto, and a Senior Investigator at the Lunenfeld-Tanenbaum Research Institute at Mount Sinai Hospital, Toronto. Educated in the UK, he received a BSc in Pharmacology from the University of Bristol and a Ph.D. from the School of Pharmacy, University College London in the field of neuroscience. Following postdoctoral appointments at the University of British Columbia (UBC), in Vancouver, and at the University of New South Wales, in Sydney, he returned to the UK to establish a laboratory at the University of Bristol. He has served as Chair of the Department of Pharmacology at the University of Birmingham (UK), the Department of Anatomy at the University of Bristol and, most recently, the Department of Physiology at the University of Toronto. He was the founding Director of the MRC Centre for Synaptic Plasticity at the University of Bristol from 1999 until 2012 and retains a post within the School of Physiology, Pharmacology and Neuroscience in Bristol. Collingridge has held visiting ships at UBC and at Seoul National University, in South Korea. He has served as the President of the British Neuroscience Association and is currently the President of the Canadian Physiological Society. He served as Editor-in-Chief of Neuropharmacology from 1993 until 2010 and is currently a reviews editor for Molecular Brain. He is a Founder Fellow of the European DANA Alliance and a Founder Fellow of the Academy of Medical Sciences (UK). In 2001 he was elected a Fellow of The Royal Society. He serves on the scientific advisory board of Hello Bio and Brain Canada. Amongst the many recognitions for his research, Collingridge was, in 2016, a co-recipient with s Tim Bliss FRS and Richard Morris FRS of The Brain Prize, which is often regarded as the “Nobel Prize of Neuroscience." In 2019, he was appointed a Commander of the Order of the British Empire (CBE) in the Queen’s birthday honours.
MEDIA
Showing media thumbnail 1 out of 1.
INSTITUTIONAL STRATEGIC INITIATIVES
- MITO2i (Mitochondrial Innovation Initiative)